N🟁N

Rodman & Renshaw Announces Discussion on DNA Radiowaves: Impact on Diagnostic and Treatment of Chronic Diseases with Nobel Priz

  //business-finance.news-articles.net/content/201 .. eatment-of-chronic-diseases-with-nobel-priz.html
  Published in Business and Finance on Tuesday, April 12th 2011 at 5:35 GMT by Market Wire
          ^{🞛 This publication is a summary or evaluation of another publication}

NEW YORK--([ BUSINESS WIRE ])--Rodman & Renshaw, LLC, a wholly owned subsidiary of Rodman & Renshaw Capital Group, Inc. (NASDAQ: RODM), today announced that Rodman will host Nobel Prize Winner, Luc Montagnier, M.D., Ph.D., for a discussion in Rodmana™s media center, on Thursday, April 14^th, 2011. The event will be moderated by Elemer Piros, Ph.D., Senior Biotechnology Analyst at Rodman & Renshaw, LLC. The topics to be covered will include the diagnosis and treatment of microbial and viral factors associated with cancer, neurodegenerative and articular diseases using innovative technologies, namely the detection of electromagnetic waves induced by DNA.

The presentation will take place at the Rodman & Renshaw Offices (1251 Avenue of the Americas, 20^th Floor, New York, NY 10020) at 4:30 PM ET on Thursday, April 14^th. To attend, please RSVP to Jordyn Kopin at [ jkopin@rodm.com ]. Please respond quickly as space is limited. This event will also be webcast live at [ www.rodm.tv ] and it will be broadcast via conference call at the following dial-in number: 877-852-6575, Passcode: 6015813. A replay of the discussion will be made available at [ www.rodm.tv ] 24-hours after completion of the event.

About Rodman & Renshaw

Rodman & Renshaw Capital Group, Inc. (NASDAQ: RODM) is a holding company with a number of direct and indirect subsidiaries, including Rodman & Renshaw, LLC.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. Rodman also provides research and sales and trading services to institutional investors. Rodman is the leader in the PIPE (private investment in public equity) and RD (registered direct offering) transaction markets. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005.

For more information visit Rodman & Renshaw on the Internet at [ www.rodm.com ]

MEMBER FINRA, SIPC